Anwaar Al-Zireeni

Anwaar Al-Zireeni

Anwaar is a two-time graduate of the University of California, Berkeley, with a B.S. and M.Eng. in Bioengineering. An entrepreneur at heart, she invented Privail's technology with the goal of increasing global access to actionable diagnostics.

San Francisco, California, United States
Member since December 22, 2014
Knowledge is power, for it enables individuals to take control of their lives and enhance their health. Quote_down
  • About
2011 University of California, Berkeley , BS , Bioengineering
2014 University of California, Berkeley , MS , Bioengineering

I am a(n):


Companies I've founded or co-founded:
Privail, Inc.
If you're an entrepreneur or corporate innovator, why?

I want to develop technologies that empower patients.

My favorite startups:

Theranos, uBiome

What's most frustrating and rewarding about entrepreneurship/innovation?

It takes A LOT out of you and requires you to sacrifice, yet I feel that this is the most impactful work I've ever done in my life.

What's the No. 1 mistake entrepreneurs/innovators make?

Not acting immediately upon sunk costs. Time is important, and if something isn't working, pivot!

What are the top three lessons you've learned as an entrepreneur?

1. A great team is your key to success
2. Go with your gut and don't take every piece of advice so literally.
3. Patience, perseverance, and confidence.

Full bio

Anwaar is a strong believer that knowledge is power, for it enables individuals to take control of their lives and enhance their health. With that in mind, she developed Privail’s diagnostic platform as a means of providing patients with the right information, at the right time, and thus enabling them to take earlier action in seeking medical treatment.  

She is a graduate of UC Berkeley's Fung Institute for Engineering Leadership, where she developed the skills necessary to integrate engineering and entrepreneurial perspectives to successfully drive early-stage ventures, such a Privail. Anwaar's time at Berkeley also provided her with proficient research experience and unique insight on the translation of research into novel clinical applications.